vidarabine has been researched along with Carcinoma, Epidermoid in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Montgomery, JA; Secrist, JA; Shortnacy, AT | 1 |
| Hanke, C; Shah, M; Wald, J | 1 |
| Streu, E | 1 |
| Al-Ahmari, A; Al-Jefri, A; Al-Musa, A; Al-Seraihy, A; Ayas, M; El-Solh, H; Khairy, A; Markiz, S; Shahin, H; Siddiqui, K | 1 |
| Borelli, S; Herr, D; Kempf, W; Trojan, A | 1 |
| Hirschman, R; Mastan, A; Ng, R; Rashid, K; Sager, D | 1 |
| Brinkman, W; Heaton, D; Mustafi, R; Schwartz, JL | 1 |
| Collins, KA; Davda, RK; Kitchens, CS | 1 |
| Ballin, A; Davidovitz, Y; Meytes, D | 1 |
| Clausen, NT; Hansen, PB; Larsen, CR | 1 |
| Ang, KK; Beauduin, M; Garden, AS; Grégoire, V; Hamoir, M; Hittelman, WN; Humblet, Y; Khuri, FR; Milas, L; Mitine, C; Rosier, JF; Scalliet, P | 1 |
| Akita, Y; Asakura, H; Kosaka, N; Majima, H; Suzuki, N | 1 |
1 trial(s) available for vidarabine and Carcinoma, Epidermoid
| Article | Year |
|---|---|
A phase I study of fludarabine combined with radiotherapy in patients with intermediate to locally advanced head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Mouth Neoplasms; Otorhinolaryngologic Neoplasms; Radiation Injuries; Vidarabine | 2002 |
11 other study(ies) available for vidarabine and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Synthesis and biological evaluation of 2-fluoro-8-azaadenosine and related compounds.
Topics: Adenosine; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line; Drug Evaluation, Preclinical; Humans; Indicators and Reagents; Laryngeal Neoplasms; Leukemia P388; Leukemia, Experimental; Magnetic Resonance Spectroscopy; Mice; Spectrophotometry, Ultraviolet; Structure-Activity Relationship | 1983 |
Eruptive Squamous Cell Carcinomas Following Treatment With Fludarabine and Discussion of Treatment.
Topics: Carcinoma, Squamous Cell; Humans; Skin Neoplasms; Vidarabine | 2023 |
Second malignancies in chronic lymphocytic leukemia.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chlorambucil; Combined Modality Therapy; Ear Neoplasms; Early Diagnosis; Humans; Immunocompromised Host; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemic Infiltration; Male; Neoplasms, Second Primary; Risk; Rituximab; Skin; Skin Neoplasms; Vidarabine | 2014 |
Factors affecting the outcome of related allogeneic hematopoietic cell transplantation in patients with Fanconi Anemia.
Topics: Adolescent; Carcinoma, Squamous Cell; Child; Child, Preschool; Cyclophosphamide; Cystitis; Fanconi Anemia; Female; Gamma Rays; Hematopoietic Stem Cell Transplantation; Hemorrhage; Histocompatibility Testing; Humans; Infant; Male; Myeloablative Agonists; Oropharyngeal Neoplasms; Retrospective Studies; Siblings; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Unrelated Donors; Vidarabine | 2014 |
Fludarabine: risk factor for aggressive behaviour of squamous cell carcinoma of the skin?
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Humans; Immunocompromised Host; Lymphoma, B-Cell; Male; Skin Neoplasms; T-Lymphocytes; Vidarabine | 2005 |
Accelerated growth of skin carcinoma following fludarabine therapy for chronic lymphocytic leukemia.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fatal Outcome; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome; Vidarabine | 2005 |
Enhancement of X-ray toxicity in squamous cell carcinoma cell lines by DNA polymerase inhibitors.
Topics: Aphidicolin; Carcinoma, Squamous Cell; Cell Survival; Cytarabine; DNA Repair; DNA Replication; DNA, Neoplasm; Humans; In Vitro Techniques; Nucleic Acid Synthesis Inhibitors; Tumor Cells, Cultured; Vidarabine; X-Rays | 1994 |
Case report: fatal Staphylococcus aureus sepsis from single-donor platelet transfusion.
Topics: Aged; Antineoplastic Agents; Bacteremia; Blood Donors; Carcinoma, Squamous Cell; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Platelet Transfusion; Skin Neoplasms; Staphylococcal Infections; Staphylococcus aureus; Thrombocytopenia; Vidarabine | 1994 |
Flare-up of squamous cell carcinoma of the skin following fludarabine therapy for chronic lymphocytic leukemia.
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; CD4 Lymphocyte Count; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Skin Neoplasms; Vidarabine | 1997 |
Aggressive growth of epithelial carcinomas following treatment with nucleoside analogues.
Topics: 2-Chloroadenosine; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Immunosuppressive Agents; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Nucleosides; Vidarabine | 2002 |
[Enhancement of radiation response of SqII mouse tumors by combined treatment with misonidazole, vidarabine, and ACNU].
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Male; Mice; Misonidazole; Nimustine; Nitrosourea Compounds; Vidarabine | 1987 |